Quality Control Testing of Lateral Flow Test Kits

Tender description

To obtain independent assurance that SARS CoV-2 Antigen qualitative test kits for clinical samples are consistently performing accurately in line with manufacturer claims and to identify any batches of test kits that may not be operating optimally. To obtain independent assurance that the test kit sampling swabs are sterile prior to use. The consequence of doing nothing is that the tests above an expected failure rate will be delayed deploying into the mission.